We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Massachusetts

  • April 29, 2015

    Aveo Board Dumps Cancer Drug Derivative Suit

    Board members at Aveo Pharmaceuticals Inc. dodged a derivative suit Tuesday when a Massachusetts federal judge ruled that the plaintiff didn't back her claims that the board was liable and should have taken her complaints about the company's kidney cancer drug tivozanib to them first.

  • April 28, 2015

    Device Maker Accused Of Firing Accountant Over FCA Claims

    A former accountant at a medical device company said in a three-count complaint in Massachusetts federal court Tuesday she was fired for bringing False Claims Act violations to management’s attention, even though she should have been protected as a whistleblower.

  • April 28, 2015

    Sen. Warren Calls Out Annuity Cos. For Lavish Sales Gifts

    U.S. Sen. Elizabeth Warren, D-Mass., expressed concern Tuesday that retirement advisers are giving clients bad advice in exchange for lavish gifts and trips, warning annuities companies such as AIG Inc. and Metlife Inc. that the incentives could represent a conflict of interest.

  • April 27, 2015

    5 Biotechs Set Stage For $415M Wave Of IPOs

    Five more biotechs — including cancer immunotherapy, painkiller, muscular dystrophy treatment and skin care developers, several of which are backed by venture capital firms —  inched closer Monday to going public, setting terms to raise roughly $415 million combined as life sciences companies continue flooding the market.

  • April 27, 2015

    Ropes & Gray, Dechert Guide $1.9B Fiber Network Cos. Merger

    Private equity-backed fiber optic network service providers Lightower Fiber Networks, represented by Ropes & Gray LLP, and Fibertech Networks, guided by a Dechert LLP team, said Monday they are merging in a $1.9 billion cash deal creating a major fiber network player in the Northeast, Mid-Atlantic and Midwest.

  • April 24, 2015

    Biolitec's Contempt Fine Capped At $70M In IP Dispute

    A Massachusetts federal judge on Wednesday capped contempt sanctions against an affiliate of Biolitec AG at $70 million in a patent dispute, saying the amount was a “reasonable penalty” to induce the German laser company to comply with the court’s preliminary injunction forbidding it to merge with an Austrian company.

  • April 24, 2015

    BU Says Epistar 'Death Penalty' Sanction Should Be Nixed

    Trustees of Boston University told a Massachusetts federal court on Thursday to reject Epistar Corp.'s bid for a so-called death penalty sanction that would strike all of the university's expert testimony in a suit accusing Epistar of infringing semiconductor technology, saying that Epistar's request lacks any legal basis.

  • April 24, 2015

    Marvel Stole 'Iron Man' Armor From Comic, Suit Says

    A new lawsuit says Walt Disney's Marvel Comics stole the futuristic suit of armor seen in the blockbuster “Iron Man” movies from two artists who once worked for the comic book giant.

  • April 23, 2015

    1st Circ. Lets Stand Order To Produce Logs In Visa, Wage Suit

    The First Circuit declined Wednesday to review a lower court's decision ordering a legal services organization to provide privilege logs from its study of labor practices at carnivals as part of an employment and immigration class action, saying it’s too early to appeal a discovery ruling.

  • April 22, 2015

    Fish Nabs Cybersecurity Ace Who Served As DHS' Counsel

    Fish & Richardson PC said Wednesday it has bolstered its Boston commercial litigation group by luring a national cybersecurity expert who once served as the U.S. Department of Homeland Security's acting general counsel.

  • April 20, 2015

    Cancer-Focused Blueprint Medicines Prepares $115M IPO

    Venture capital-backed Blueprint Medicines Corp., led by Goodwin Procter LLP, set terms on Monday to draw roughly $115 million in its initial public offering, setting the stage for the latest cancer-focused biopharmaceutical company to tap the public market.

  • April 20, 2015

    Whistleblowers Appeal Dismissal Of Novartis FCA Xolair Suit

    Whistleblowers who accused Novartis Pharmaceuticals Corp. and Genentech Inc. of off-label marketing and providing kickbacks to sell an asthma drug are appealing a Massachusetts federal judge’s dismissal of their False Claims Act suit.

  • April 17, 2015

    J&J Can't Dodge $63M Verdict In Children's Motrin Case

    Massachusetts' highest court on Friday upheld a $63 million jury verdict against Johnson & Johnson for allegedly inadequate warnings about the health risks posed by its fever and pain drug Children's Motrin, finding that the Supreme Court's landmark Levine decision did not preempt the plaintiffs' claims.

  • April 16, 2015

    EEOC Wants Coding Info In Steakhouse Age Bias Suit

    The U.S. Equal Employment Opportunity Commission asked a Massachusetts federal judge on Wednesday to force Texas Roadhouse Inc. to produce computer coding information to help speed up its ongoing discovery battle in its age bias suit against the steakhouse restaurant chain.

  • April 16, 2015

    1st Circ. Sticks With Revival Of Universal Health FCA Suit

    The First Circuit on Tuesday denied Universal Health Services Inc.'s petition for an en banc rehearing on the revival and remand of a False Claims Act case accusing the company of seeking reimbursement for poor care.

  • April 15, 2015

    1st Circ. Won't Rehear Conviction Tied To Rwanda Genocide

    The First Circuit on Wednesday refused to reconsider its decision upholding the criminal conviction of a Rwandan woman who allegedly lied to immigration officials about her ties to the mass killings that ravaged the Central African nation in the mid-1990s in order to gain entry into the U.S.

  • April 15, 2015

    Nelson Mullins Adds Ex-Goodwin Procter Class Action Pro

    A former Goodwin Procter LLP partner with experience defending financial institutions and mortgage lenders in consumer class actions has joined Nelson Mullins Riley & Scarborough LLP’s Boston office, the firm said Tuesday.

  • April 13, 2015

    Ex-Execs Of Co. Sold To J&J Charged With Securities Fraud

    The former CEO and vice president of sales of Acclarent Inc., a company sold to Johnson & Johnson in 2010, were charged with securities fraud in connection with the allegedly illegal marketing of a medical device in order to drive up the company’s valuation ahead of a buyout, federal prosecutors said Friday.

  • April 10, 2015

    Prograf Antitrust MDL Lawyers Seek $34M In Fees

    Attorneys for certain buyers of organ transplant anti-rejection drug Prograf sought $34 million in fees and expenses Thursday, three months after reaching a $98 million deal with Astellas Pharma US Inc. over allegations it delayed entry of a generic form of the immunosuppressant.

  • April 9, 2015

    Apple, Micron Want Plug Pulled On MIT's Chip Patent Suit

    Apple Inc. and Micron Technology Inc. on Thursday urged a Massachusetts federal judge to toss the Massachusetts Institute of Technology’s suit alleging Micron-made semiconductors imported into the country in iPhones and iPads infringe MIT’s laser cutting patent, arguing the patent only covers the process,  not the products.